Genotypic

Genotypic is a leader in the field of genomics, known for delivering high-quality, tailored genomics solutions. The company serves as a reliable partner for both academia and industry, providing comprehensive support from the initial concept through to execution and publication.

Their R&D team is dedicated to enhancing genomic and bioinformatics technologies, aiming to create innovative applications in biomedical research and agriculture. Genotypic's efforts are recognized by the Department of Scientific and Industrial Research (DSIR) of the Government of India.

Genotypic has been awarded notable grants, such as those from the NIH for transcriptional analysis of tuberculosis in guinea pig models and from the DBT for biomarker discovery in HIV-TB co-infection.

Founded in 1998, Genotypic is India's first genomics company, pioneering advancements in Next-Generation Sequencing (NGS), Microarray, and Bioinformatics. They offer comprehensive genomics solutions to pharmaceutical and biotech companies, as well as academic institutions globally. Their mission is to simplify complex genomics and bridge the gap between biology and technology, facilitating groundbreaking research and discoveries.

The management team includes Dr. Raja, a seasoned technocrat-turned-entrepreneur who founded Genotypic and QTLomics, India's first agri-genomics company. He is an elected member of the Association of Biotech Led Enterprises of India (ABLE) and collaborates with start-ups and incubators to promote genomics innovations.

Dr. Sudha, co-founder of Genotypic Technology, has over twenty years of experience in research and entrepreneurship. She also established Dhiti Omics Technology, a molecular diagnostics company, and has been instrumental in setting up Genotypic’s world-class genomics facility and processes for Microarray, Molecular Biology, and NGS.